Amid growing infection of the corona epidemic, scientists from all over the world are engaged in making its vaccine. Meanwhile, Favipiravir, an antiviral drug for early corona patients in India, has been allowed to be manufactured and marketed under the name of Fabiflu. There are also good reports about the progress of the vaccine.
However, due to the length of the clinical trial process, it is delayed. According to reports, more than 100 types of vaccines for corona are being researched worldwide.
Expectations have been raised from the Oxford University's Corona Vaccine AZD1222, amidst clinical trials of different phages on multiple vaccines. This vaccine is also called the ChAdOx1 nCoV-19 vaccine. This vaccine helps identify the spike proteins of the virus in the body. With the recent development of the Sputnik-V COVID vaccine by Russia we are bound to see an ultimate COVID-19 vaccine for the whole world.
According to various media surveys and polls we can expect a shortcoming and see the deadline of corona vaccine's arrival by minimum December or by maximum next year, maybe by March-April (maximum) depending upon increasing or decreasing factors.
